Daniela Tapia‐Trejo

483 total citations
25 papers, 228 citations indexed

About

Daniela Tapia‐Trejo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Daniela Tapia‐Trejo has authored 25 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 16 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Daniela Tapia‐Trejo's work include HIV/AIDS Research and Interventions (18 papers), HIV Research and Treatment (16 papers) and HIV/AIDS drug development and treatment (14 papers). Daniela Tapia‐Trejo is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), HIV Research and Treatment (16 papers) and HIV/AIDS drug development and treatment (14 papers). Daniela Tapia‐Trejo collaborates with scholars based in Mexico, United States and Guatemala. Daniela Tapia‐Trejo's co-authors include Santiago Ávila‐Ríos, Gustavo Reyes‐Terán, Claudia García‐Morales, Margarita Matías‐Florentino, Juan Sierra‐Madero, Carlos Magis‐Rodríguez, Paul Sandstrom, Hezhao Ji, Patricia Uribe-Zúñiga and Carlos Mejía-Villatoro and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Daniela Tapia‐Trejo

23 papers receiving 222 citations

Peers

Daniela Tapia‐Trejo
Joshua M Chevalier United States
Kenny Dauwe Belgium
Anna Tostevin United Kingdom
Erin Rottinghaus United States
Daniela Tapia‐Trejo
Citations per year, relative to Daniela Tapia‐Trejo Daniela Tapia‐Trejo (= 1×) peers Claudia García‐Morales

Countries citing papers authored by Daniela Tapia‐Trejo

Since Specialization
Citations

This map shows the geographic impact of Daniela Tapia‐Trejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Tapia‐Trejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Tapia‐Trejo more than expected).

Fields of papers citing papers by Daniela Tapia‐Trejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Tapia‐Trejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Tapia‐Trejo. The network helps show where Daniela Tapia‐Trejo may publish in the future.

Co-authorship network of co-authors of Daniela Tapia‐Trejo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Tapia‐Trejo. A scholar is included among the top collaborators of Daniela Tapia‐Trejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Tapia‐Trejo. Daniela Tapia‐Trejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morey, Francis, Amalia Girón‐Callejas, Aspiro Nayim Urbina, et al.. (2024). Pretreatment and acquired HIV drug resistance in Belize—results of nationally representative surveys, 2021–22. Journal of Antimicrobial Chemotherapy. 80(1). 292–300. 1 indexed citations
2.
Urbán, S. Cabrera, Amalia Girón‐Callejas, Héctor Chiparelli, et al.. (2023). HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay—Results of a Nationally Representative Survey, 2018–2019. Viruses. 15(2). 490–490. 1 indexed citations
4.
Truong, Hong‐Ha M., Claudia García‐Morales, Daniela Tapia‐Trejo, et al.. (2022). HIV drug resistance in persons initiating or reinitiating first‐line antiretroviral therapy in Paraguay: Results of a National Patient Survey. Journal of Medical Virology. 94(10). 5061–5065. 3 indexed citations
5.
Tapia‐Trejo, Daniela, et al.. (2022). A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City. International Journal of Infectious Diseases. 125. 114–119. 1 indexed citations
6.
Girón‐Callejas, Amalia, Claudia García‐Morales, Ana Nieto, et al.. (2022). High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018–2019. Open Forum Infectious Diseases. 9(11). 53–56. 1 indexed citations
7.
Caro‐Vega, Yanink, Daniela Tapia‐Trejo, Pablo F. Belaunzarán-Zamudio, et al.. (2022). Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City. PLoS ONE. 17(3). e0264964–e0264964. 4 indexed citations
8.
García‐Morales, Claudia, Margarita Matías‐Florentino, Daniela Tapia‐Trejo, et al.. (2021). Characteristics and growth of the genetic HIV transmission network of Mexico City during 2020. Journal of the International AIDS Society. 24(11). e25836–e25836. 8 indexed citations
9.
Panpradist, Nuttada, Ingrid A. Beck, Santiago Ávila‐Ríos, et al.. (2020). Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort. AIDS. 34(9). 1331–1338. 12 indexed citations
10.
Vrancken, Bram, Sanjay R. Mehta, Santiago Ávila‐Ríos, et al.. (2020). Dynamics and Dispersal of Local Human Immunodeficiency Virus Epidemics Within San Diego and Across the San Diego–Tijuana Border. Clinical Infectious Diseases. 73(7). e2018–e2025. 18 indexed citations
11.
Girón‐Callejas, Amalia, Claudia García‐Morales, Daniela Tapia‐Trejo, et al.. (2019). High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016. Journal of the International AIDS Society. 22(12). e25429–e25429. 6 indexed citations
12.
Mendoza, Yaxelis, Claudia García‐Morales, Gonzalo Bello, et al.. (2018). Evolutionary history and spatiotemporal dynamics of the HIV-1 subtype B epidemic in Guatemala. PLoS ONE. 13(9). e0203916–e0203916. 2 indexed citations
13.
Chaillon, Antoine, Santiago Ávila‐Ríos, Joel O. Wertheim, et al.. (2017). Identification of major routes of HIV transmission throughout Mesoamerica. Infection Genetics and Evolution. 54. 98–107. 12 indexed citations
14.
García‐Morales, Claudia, et al.. (2017). HIV pretreatment drug resistance trends in three geographic areas of Mexico. Journal of Antimicrobial Chemotherapy. 72(11). 3149–3158. 11 indexed citations
15.
Ávila‐Ríos, Santiago, Claudia García‐Morales, Margarita Matías‐Florentino, et al.. (2016). Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey. The Lancet HIV. 3(12). e579–e591. 70 indexed citations
16.
Ávila‐Ríos, Santiago, et al.. (2016). HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015. PLoS ONE. 11(10). e0164156–e0164156. 12 indexed citations
17.
Mendoza, Yaxelis, Alexander A. Martínez, Yamitzel Zaldívar, et al.. (2016). HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes. PLoS ONE. 11(4). e0154317–e0154317. 15 indexed citations
18.
Ávila‐Ríos, Santiago, Claudia García‐Morales, Daniela Tapia‐Trejo, et al.. (2015). HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy. PLoS ONE. 10(11). e0142604–e0142604. 12 indexed citations
19.
Ávila‐Ríos, Santiago, Claudia García‐Morales, Daniela Tapia‐Trejo, et al.. (2015). O331: HIV drug resistance in treatment-naïve individuals in Mesoamerica. Journal of the International AIDS Society. 18(3 (Suppl 2)). 10 indexed citations
20.
Ávila‐Ríos, Santiago, Claudia García‐Morales, Daniela Tapia‐Trejo, et al.. (2014). HIV-1 Drug Resistance Surveillance in Antiretroviral Treatment-Naive Individuals from a Reference Hospital in Guatemala, 2010–2013. AIDS Research and Human Retroviruses. 31(4). 401–411. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026